Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group

Treatment options for myelodysplastic syndromes (MDS) vary widely, depending on the natural disease course and patient‐related factors. Comparison of treatment effectiveness is challenging as different endpoints have been included in clinical trials and outcome reporting. Our goal was to develop the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Haematol
Main Authors: Rochau, Ursula, Stojkov, Igor, Conrads‐Frank, Annette, Borba, Helena H., Koinig, Karin A., Arvandi, Marjan, van Marrewijk, Corine, Garelius, Hege, Germing, Ulrich, Symeonidis, Argiris, Sanz, Guillermo F., Fenaux, Pierre, de Witte, Theo, Efficace, Fabio, Siebert, Uwe, Stauder, Reinhard
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Haematological Malignancy ‐ Clinical
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8221029/
https://ncbi.nlm.nih.gov/pubmed/32410281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16654
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki